📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Conjugation to PEG as a Strategy to Limit the Uptake of Drugs by the Placenta: Potential Applications for Drug Administration in Pregnancy. (2022)

First Author: Dodd A

Attributed to: Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.1c00498

PubMed Identifier: 34842438

Publication URI: http://europepmc.org/abstract/MED/34842438

Type: Journal Article/Review

Volume: 19

Parent Publication: Molecular pharmaceutics

Issue: 1

ISSN: 1543-8384